·07/05/08 The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
·07/05/08 Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis
·07/05/08 An inducible caspase 9 safety switch for T-cell therapy
·07/05/08 Failure of SCID-X1 gene therapy in older patients
·07/05/08 Thrombopoietin enhances expression of vascular endothelial growth factor (VeGF) in primitive hematopoietic cells through induction of HIF-1
·07/05/08 A systematic scan of interactions with tyrosine motifs in the erythropoietin receptor using a mammalian 2-hybrid approach
·07/05/08 Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2
·07/05/08 Identification and characterization of undifferentiated mast cells in mouse bone marrow
·07/05/08 Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis
·07/05/08 Shared and distinct roles mediated through C-terminal subdomains of acute myeloid leukemia/Runt-related transcription factor molecules in murine development
·07/05/08 Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2
·07/05/08 Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells
·07/05/08 Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion
·07/05/08 Sema4D induces angiogenesis through Met recruitment by Plexin B1
·07/05/08 endothelial apoptosis induced by inhibition of integrins v3 and v5 involves ceramide metabolic pathways
·07/05/08 Thrombin-catalyzed activation of factor VIII with His substituted for Arg372 at the P1 site
·07/05/08 Selective impairment of platelet activation to collagen in the absence of GATA1
·07/05/08 Negative thymocyte selection to HeRV-K18 superantigens in humans
·07/05/08 SAP controls the cytolytic activity of CD8+ T cells against eBV-infected cells
·07/05/08 Identification and characterization of circulating human transitional B cells
·07/05/08 Induction of tumor NK-cell immunity by anti-CD69 antibody therapy
·07/05/08 Omenn syndrome due to ARTeMIS mutations
·07/05/08 Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow
·07/05/08 A proportion of patients with lymphoma may harbor mutations of the perforin gene
·07/05/08 A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival
·07/05/08 TeF, an antiapoptotic bZIP transcription factor related to the oncogenic e2A-HLF chimera, inhibits cell growth by down-regulating expression of the common chain of cytokine receptors
·07/05/08 Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome
·07/05/08 A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules
·07/05/08 Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP
·07/05/08 Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VeGF
·07/05/08 Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo
·07/05/08 Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival
·07/05/08 Leukocyte migration and graft-versus-host disease
·07/05/08 A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival
·07/05/08 Multifunctional role of erk5 in multiple myeloma

1 [2] [下一页] [尾页]